These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7584876)

  • 41. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
    Beshyah SA; Kyd P; Thomas E; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlations between new markers of bone formation versus bone resorption in kidney transplant recipients.
    Małyszko J; Wolczyński S; Małyszko JS; Myśliwiec M
    Transplant Proc; 2002 Mar; 34(2):591-2. PubMed ID: 12009634
    [No Abstract]   [Full Text] [Related]  

  • 44. Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.
    Nagasaka S; Sugimoto H; Nakamura T; Kusaka I; Fujisawa G; Sakuma N; Tsuboi Y; Fukuda S; Honda K; Okada K; Ishikawa S; Saito T
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):215-21. PubMed ID: 9302397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
    Elomaa I; Virkkunen P; Risteli L; Risteli J
    Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical markers of bone turnover.
    Fraher LJ
    Clin Biochem; 1993 Dec; 26(6):431-2. PubMed ID: 8124854
    [No Abstract]   [Full Text] [Related]  

  • 47. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
    Hassager C; Jensen LT; Pødenphant J; Thomsen K; Christiansen C
    Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased degradation of type I collagen in patients with inflammatory bowel disease.
    Silvennoinen J; Risteli L; Karttunen T; Risteli J
    Gut; 1996 Feb; 38(2):223-8. PubMed ID: 8801201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spontaneous osteonecrosis of the knee: biochemical markers of bone turnover and pathohistology.
    Berger CE; Kröner A; Kristen KH; Minai-Pour M; Leitha T; Engel A
    Osteoarthritis Cartilage; 2005 Aug; 13(8):716-21. PubMed ID: 15922633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low serum levels of intact osteocalcin in patients with congestive heart failure.
    Schleithoff SS; Zittermann A; Stüttgen B; Tenderich G; Berthold HK; Körfer R; Stehle P
    J Bone Miner Metab; 2003; 21(4):247-52. PubMed ID: 12811631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of a serum carboxyterminal pyridinoline cross-linked telopeptide of type I collagen as a quantitative screening marker for bone metastases in patients with urological malignancies.
    Okamura T; Akita H; Tatsura H; Kawai N; Nagata D; Azemoto M; Iwase Y; Kohri K
    Cancer Detect Prev; 2003; 27(1):14-8. PubMed ID: 12600412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concentration of the cross-linked carboxyterminal telopeptide of type I collagen in serum of young growing rats fed a low calcium and vitamin D-deficient diet.
    Bielaczyc AR; Gołebiewska M; Citko A; Rogowski F
    Eur J Clin Chem Clin Biochem; 1997 Dec; 35(12):915-8. PubMed ID: 9476619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of bone metastasis from lung cancer.
    Horiguchi T; Tachikawa S; Kondo R; Hirose M; Teruya S; Ishibashi A; Banno K
    Jpn J Clin Oncol; 2000 Apr; 30(4):174-9. PubMed ID: 10830985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
    Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
    Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers of bone turnover after a short period of steroid therapy in elderly men.
    Paglia F; Dionisi S; De Geronimo S; Rosso R; Romagnoli E; Raejntroph N; Ragno A; Celi M; Pepe J; D'Erasmo E; Minisola S
    Clin Chem; 2001; 47(7):1314-6. PubMed ID: 11427468
    [No Abstract]   [Full Text] [Related]  

  • 58. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
    Woitge HW; Scheidt-Nave C; Kissling C; Leidig-Bruckner G; Meyer K; Grauer A; Scharla SH; Ziegler R; Seibel MJ
    J Clin Endocrinol Metab; 1998 Jan; 83(1):68-75. PubMed ID: 9435418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible variation in bone resorption during the normal menstrual cycle.
    Schlemmer A; Hassager C; Risteli J; Risteli L; Jensen SB; Christiansen C
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):388-92. PubMed ID: 8279219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.